共 125 条
[1]
Yuyun MF(2020)Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries An Epidemiological Perspective 15 1-18
[2]
Sliwa K(2015)Heart disease and stroke statistics—2015 update: a report from the American Heart Association Circulation. 131 e29-322
[3]
Kengne AP(2018)Data on the epidemiology of heart failure in sub-Saharan Africa Data Br 17 1218-1239
[4]
Olga A(2017)Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: A prospective cohort of Ugandan inpatients BMJ Open 7 1-11
[5]
Bukhman G(2020)An overview of heart failure in low- and middle-income countries Cardiovasc Diagn Ther 10 244-251
[6]
Mozaffarian D(2021)2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J 42 3599-3726
[7]
Benjamin EJ(2017)2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart failure Society of Amer J Am Coll Cardiol 70 776-803
[8]
Go AS(2015)Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates Int J Clin Pharm 37 105-112
[9]
Arnett DK(2012)ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart Eur Heart J 33 1787-1847
[10]
Blaha MJ(2000)Adverse drug reactions: definitions, diagnosis, and management Lancet. 356 1255-1259